The Bharatiya Janata Party (BJP) Central Election Committee met on Wednesday at the party’s headquarters in Delhi to finalize the names of the party’s remaining candidates for the Rajasthan and Telangana assembly elections.
The meeting was attended by Prime Minister Narendra Modi, Union Home Minister Amit Shah, the party’s national president JP Nadda, and other dignitaries.
The first phase of the meeting focused on the Rajasthan Assembly elections and the party list of candidates for the remaining 76 seats, while the second phase focused on the Telangana Assembly elections.
During the discussion on 76 seats of Rajasthan, BJP leader and Union Minister Gajendra Singh Shekhawat, election in-charge Prahlad Joshi, and Union Minister Arjun Ram Meghwal were among the leaders who were present.
According to sources, the list of 40 to 50 seats may be released today, Thursday.
However, as per the sources, consensus could not be reached on some seats, due to which discussion was held on the remaining seats at the residence of election in-charge Prahlad Joshi.
Election in-charge Prahlad Joshi, Union Jal Shakti Minister Gajendra Singh Shekhawat, State in-charge Arun Singh, State President CP Joshi, former Chief Minister Vasundhara Raje, co-in-charge Vijaya Rahatkar, Union Minister Kailash Chaudhary, Minister Arjun Ram Meghwal were present in the meeting which was held at Joshi’s residence.
The BJP has been making vigorous efforts to return to power in the Congress-ruled Rajasthan.
Mark Zuckerberg's remark about India's 2024 elections, facing backlash from officials who emphasized the government’s…
Delhi Congress president Devender Yadav, accompanied by Jharkhand Minister for Panchayati Raj Dipika Pandey Singh,…
The relationship between gut microbes, hormones, and dietary preferences is a fascinating area of study…
AI systems like ChatGPT have been linked to environmental concerns, with reports showing their significant…
Rabi Lamichhane, RSP chief and ex-home minister, secures bail in the Swarnalakshmi Cooperative fraud case…
Metformin, the widely prescribed drug for managing type 2 diabetes, has recently gained attention for…